218 related articles for article (PubMed ID: 36285406)
1. Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.
Grilo CM; Lydecker JA; Fineberg SK; Moreno JO; Ivezaj V; Gueorguieva R
Am J Psychiatry; 2022 Dec; 179(12):927-937. PubMed ID: 36285406
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial.
Grilo CM; Lydecker JA; Gueorguieva R
Psychol Med; 2023 Dec; 53(16):7775-7784. PubMed ID: 37366017
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.
Grilo CM; Lydecker JA; Jastreboff AM; Pittman B; McKee SA
Obesity (Silver Spring); 2023 Nov; 31(11):2762-2773. PubMed ID: 37751990
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
[TBL] [Abstract][Full Text] [Related]
5. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
Grilo CM; White MA
Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial testing the effectiveness of adaptive "SMART" stepped-care treatment for adults with binge-eating disorder comorbid with obesity.
Grilo CM; White MA; Masheb RM; Ivezaj V; Morgan PT; Gueorguieva R
Am Psychol; 2020; 75(2):204-218. PubMed ID: 32052995
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial.
Grilo CM; Masheb RM; Wilson GT; Gueorguieva R; White MA
J Consult Clin Psychol; 2011 Oct; 79(5):675-85. PubMed ID: 21859185
[TBL] [Abstract][Full Text] [Related]
8. Treatment of binge eating disorder.
Wilson GT
Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Behavioral Weight Loss and Stepped Care for Binge-Eating Disorder: 12-Month Follow-up.
Grilo CM; White MA; Ivezaj V; Gueorguieva R
Obesity (Silver Spring); 2020 Nov; 28(11):2116-2124. PubMed ID: 32985114
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioral therapy for binge-eating disorder for non-responders to initial acute treatments: Randomized controlled trial.
Grilo CM; Lydecker JA; Gueorguieva R
Int J Eat Disord; 2023 Aug; 56(8):1544-1553. PubMed ID: 37144325
[TBL] [Abstract][Full Text] [Related]
11. Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication.
Grilo CM; Masheb RM; White MA; Gueorguieva R; Barnes RD; Walsh BT; McKenzie KC; Genao I; Garcia R
Behav Res Ther; 2014 Jul; 58():1-9. PubMed ID: 24857821
[TBL] [Abstract][Full Text] [Related]
12. Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.
White MA; Grilo CM
J Clin Psychiatry; 2013 Apr; 74(4):400-6. PubMed ID: 23656848
[TBL] [Abstract][Full Text] [Related]
13. Psychological treatments of binge eating disorder.
Wilson GT; Wilfley DE; Agras WS; Bryson SW
Arch Gen Psychiatry; 2010 Jan; 67(1):94-101. PubMed ID: 20048227
[TBL] [Abstract][Full Text] [Related]
14. Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.
Guerdjikova AI; Walsh B; Shan K; Halseth AE; Dunayevich E; McElroy SL
Adv Ther; 2017 Oct; 34(10):2307-2315. PubMed ID: 28918581
[TBL] [Abstract][Full Text] [Related]
15. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).
Apovian CM; Aronne L; Rubino D; Still C; Wyatt H; Burns C; Kim D; Dunayevich E;
Obesity (Silver Spring); 2013 May; 21(5):935-43. PubMed ID: 23408728
[TBL] [Abstract][Full Text] [Related]
16. Rapid response predicts 12-month post-treatment outcomes in binge-eating disorder: theoretical and clinical implications.
Grilo CM; White MA; Wilson GT; Gueorguieva R; Masheb RM
Psychol Med; 2012 Apr; 42(4):807-17. PubMed ID: 21923964
[TBL] [Abstract][Full Text] [Related]
17. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.
Carbone EA; Caroleo M; Rania M; Calabrò G; Staltari FA; de Filippis R; Aloi M; Condoleo F; Arturi F; Segura-Garcia C
Eat Weight Disord; 2021 Apr; 26(3):779-788. PubMed ID: 32356145
[TBL] [Abstract][Full Text] [Related]
18. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder.
Grilo CM; Crosby RD; Wilson GT; Masheb RM
J Consult Clin Psychol; 2012 Dec; 80(6):1108-13. PubMed ID: 22985205
[TBL] [Abstract][Full Text] [Related]
19. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
20. Rapid response in psychological treatments for binge eating disorder.
Hilbert A; Hildebrandt T; Agras WS; Wilfley DE; Wilson GT
J Consult Clin Psychol; 2015 Jun; 83(3):649-54. PubMed ID: 25867446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
